Squarepoint’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$312K Buy
70,597
+43,116
+157% +$255K ﹤0.01% 3670
2025
Q4
$147K Sell
27,481
-597,326
-96% -$4.75M ﹤0.01% 3955
2025
Q3
$6.01M Buy
+624,807
New +$5.76M 0.01% 1348
2025
Q1
Sell
-58,834
Closed -$267K 4551
2024
Q4
$267K Buy
58,834
+26,219
+80% +$140K ﹤0.01% 4242
2024
Q3
$90.7K Buy
+32,615
New +$86.7K ﹤0.01% 3892
2024
Q2
Sell
-37,669
Closed -$156K 4034
2024
Q1
$156K Buy
+37,669
New +$116K ﹤0.01% 3695

Other funds holding ASPI

Squarepoint's ASPI Position: Q1 2026 in Review

Squarepoint increased its ASP Isotopes (ASPI) stake by 157% in Q1 2026, buying an estimated $255K and bringing the position to 70,597 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #3670.

Squarepoint first reported a position in ASPI in Q1 2024 and has held it in 6 quarters since. The position peaked at $6.01M in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • Squarepoint held 70,597 shares of ASP Isotopes worth $312K as of Q1 2026.
  • Squarepoint bought 43,116 ASP Isotopes shares in Q1 2026, an estimated $255K.
  • ASP Isotopes made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3670 holding.
  • Squarepoint first reported a position in ASP Isotopes in Q1 2024 and has held it in 6 quarters since.
  • Squarepoint's ASP Isotopes position peaked at $6.01M in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.